Breaking News
October 18, 2018 - FDA Approves Talzenna (talazoparib) for gBRCAm HER2-Negative Locally Advanced or Metastatic Breast Cancer
October 18, 2018 - Many U.S. adults confused about primary care, study shows
October 18, 2018 - With philanthropic gifts, Stanford poised to make major advances in neurosciences | News Center
October 18, 2018 - Researchers discover why heart contractions are weaker in individuals with HCM
October 18, 2018 - Participation in organized sport during childhood may have long-term skeletal benefits
October 18, 2018 - Probiotic/antibiotic combination could eradicate drug-resistant bacteria
October 17, 2018 - More Socioeconomic Challenges for Hispanic Women With HIV
October 17, 2018 - 49,XXXXY syndrome – Genetics Home Reference
October 17, 2018 - Scientists uncover possible new causes of Tourette syndrome
October 17, 2018 - Girl undergoes unusual heart surgery after compassionate-use exemption | News Center
October 17, 2018 - Health Issues That Are Sometimes Mistaken for Gluten Sensitivity
October 17, 2018 - Elective induction of labor at 39 weeks may be beneficial option for women and their babies
October 17, 2018 - New smart watch algorithms can accurately monitor wearers’ sleep patterns
October 17, 2018 - Researchers demonstrate epigenetic memory transmission via sperm
October 17, 2018 - FDA, DHS announce memorandum of agreement to address cybersecurity in medical devices
October 17, 2018 - Health Tip: Know the Risks of Chicken Pox
October 17, 2018 - Immunotherapy effective against hereditary melanoma
October 17, 2018 - Researchers reveal new mechanism for how animal cells stay intact | News Center
October 17, 2018 - Alzheimer's Goes Under the Cryo-Electron Microscope
October 17, 2018 - Medicare for all? CMS chief warns program has enough problems already
October 17, 2018 - Metrohm Raman introduces Mira P handheld Raman system
October 17, 2018 - Expanding the knowledge about hippocampus to better understand cognitive deficits in MS
October 17, 2018 - Study of Nigerian breast cancer patients reveals prevalence of aggressive molecular features
October 17, 2018 - Many healthy children may have metabolic risk factors, finds study
October 17, 2018 - A new antibiotic could be a better, faster treatment for tuberculosis
October 17, 2018 - “I will not become a Robot Doctor”: A medical student vows to practice compassion
October 17, 2018 - Study findings may explain sporadic outbreaks of C. difficile infections in hospitals
October 17, 2018 - Purdue researchers develop new chemical process to find better drug ‘fits’ for patients
October 17, 2018 - Yale researchers develop way to attack RNA with small-molecule drugs
October 17, 2018 - New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug
October 17, 2018 - Alnylam Announces Plan to Initiate Rolling Submission of a New Drug Application and Pursue Full Approval for Givosiran
October 17, 2018 - Nine cases of polio-like illness suspected in children in illinois
October 17, 2018 - Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries
October 17, 2018 - Patients once thought incurable can benefit from high-dose radiation therapy
October 17, 2018 - Researchers awarded grant to advance testing of experimental heroin vaccine
October 17, 2018 - Researchers examine SSRI use during pregnancy and major gestational malformations
October 17, 2018 - FDA grants Rare Pediatric Disease Designation for Immusoft’s Iduronicrin genleukocel-T
October 17, 2018 - Reliable Respiratory announces acquisition of Attleboro Area Medical Equipment
October 17, 2018 - Study reveals link between childhood abuse and higher arthritis risk in adulthood
October 17, 2018 - Research shows people over 65 are not performing enough physical activity
October 17, 2018 - FDA Approves Liletta (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Five Years
October 17, 2018 - Weight gain after smoking cessation linked to increased short-term diabetes risk
October 17, 2018 - Researchers find opportunity to control salt-sensitive hypertension without exercising
October 17, 2018 - Women not warned about cancer associated with breast implants
October 17, 2018 - Metrohm offers robust handheld Raman analyzer for Defense and Security
October 17, 2018 - Modeling Non-Numerical Data in Systems Biology
October 17, 2018 - Research aims to address health disparities in African-American men
October 17, 2018 - Human and cattle decoys trap outdoor-biting mosquitoes in malaria endemic regions
October 17, 2018 - High Circulating Prolactin Level Inversely Linked to T2DM Risk
October 17, 2018 - Study finds gene variant predisposes people to both Type 2 diabetes and low body weight
October 17, 2018 - Metrohm software products make it easy to comply with ALOCA and ALCOA+ guidelines
October 17, 2018 - Network of doctors identify the cause of 31 new conditions
October 17, 2018 - Notable improvement in brain cancer survival among younger patients but not much for elderly
October 17, 2018 - Scientists shed light on roles of transcription factors, TP63 and SOX2, in squamous cell carcinoma
October 17, 2018 - Costs of Medicare Diabetes Prevention Program may be higher than expected reimbursement
October 17, 2018 - Misuse of prescription opioids or benzodiazepines associated with suicidal thoughts
October 17, 2018 - New research seeks to address sex disparities in women’s health
October 17, 2018 - C-Section Rates Have Nearly Doubled Since 2000: Study
October 17, 2018 - Talking to Your Kids About STDs
October 17, 2018 - New classification of periodontal and peri-implant diseases and conditions
October 17, 2018 - Herbert D. Kleber, Pioneer in Addiction Treatment, Dies at 84
October 17, 2018 - Health effects of smoke-filled atmosphere
October 17, 2018 - Down syndrome may hold important clues to onset of Alzheimer’s disease
October 17, 2018 - A special report on US’ aging societies
October 17, 2018 - Birth mode may have acute effects on neurodevelopment, study suggests
October 17, 2018 - Global health innovation system fails to deliver affordable treatments to patients, says report
October 17, 2018 - Simple, inexpensive test quickly detects antibiotic-resistant ‘superbugs’
October 17, 2018 - New drugs could reduce risk of heart disease when added to statins
October 17, 2018 - Visible and valued: Stanford Medicine’s first-ever LGBTQ+ Forum
October 17, 2018 - HVP vaccination not linked with rise in teen risky sex
October 17, 2018 - Potential ‘early warning markers’ for sepsis discovered
October 17, 2018 - Who knew? Life begins (again) at 65
October 17, 2018 - Application of blood pressure guidelines ups treatment
October 17, 2018 - Stanford researchers find that small molecule may help treat enzyme deficiency
October 17, 2018 - Speed Cameras Save Money and Lives in New York City
October 17, 2018 - Men who conform to ‘the man box’ more likely to consider suicide and violence
October 17, 2018 - Researchers aim to create more authentic organoids for drug testing, transplantation
October 16, 2018 - New blood test for pediatric brain tumor patients offers safer approach than surgical biopsies
October 16, 2018 - Age-related estrogen increase may be the culprit behind inguinal hernias in men
October 16, 2018 - Skills-Based Intervention Did Not Cut Systolic BP After Stroke, TIA
TCT: Hybrid Revascularization Safe Mid-Term But Not Better … Yet

TCT: Hybrid Revascularization Safe Mid-Term But Not Better … Yet

image_pdfDownload PDFimage_print

DENVER — A hybrid surgery plus stenting procedure for multivessel coronary artery disease didn’t improve outcomes or cut residual ischemia compared with a purely surgical approach or stenting alone, a small head-to-head trial showed.

Residual ischemia at 12 months was found by single-photon emission CT (SPECT) in 6.4% of patients with left internal mammary artery grafting (LIMA) of the left anterior descending (LAD) coronary artery and drug-eluting stents for other blocked vessels compared with 6.7% of patients with coronary artery bypass grafting alone (CABG) alone and 7.9% of patients with drug-eluting stents (DESs) alone.

The 12-month freedom from major adverse cardiac and cerebral events events was 88.6% compared with 88.0% , and 86.8%, respectively among the arms, none of which differed significantly in the HREV trial.

Target vessel or graft failure was likewise similar across arms, at 11.5%, 12.0%, and 11.3%, respectively, Roman Tarasov, MD, PhD, of the State Research Institute for Complex Issues of Cardiovascular Diseases in Kemerovo, Russia, reported at a press conference here at the Transcatheter Cardiovascular Therapeutics meeting.

Press conference moderator Roxana Mehran, MD, of the Icahn School of Medicine at Mount Sinai in New York City, noted that the importance of this small study — really the first pilot study that has hybrid multivessel, PCI and CABG head-to-head — is in finding the hybrid approach is safe.

“Hybrid revascularization is something we talked about 2 decades ago. Because we knew — before drug-eluting stents came along — we knew the best therapy to LAD to protect the patient is LIMA … We know that vein grafts also don’t have the durability as a LIMA to the LAD. So the best of two worlds would be a LIMA to the LAD, and drug-eluting stents do extremely well in the non-LAD distribution, hence hybrid revascularization.”

While logistically challenging, she said, “I do believe there are a tremendous number of sites in the U.S. that have some appetite for this. Especially now with heart team approach now … we are having shared decisions with [patients] and the heart team to give them best of both worlds. But you have to prove this is the best possible treatment modality for these patients, which means long follow-up and good comparator arms.”

The Cardiothoracic Surgical Network’s Hybrid Coronary Revascularization Trial funded by the NIH should give the more definitive answer, said David Cohen, MD, of Saint Luke’s Mid-America Heart Center in America Heart Institute in Kansas City, Missouri, a press conference discussant.

“Really, the benefit of the LIMA is not the first year so much, it’s 10 years, 20 years. And I think it’s going to take something on that order to really show the benefit of this type of approach,” he said.

The trial included 150 patients randomized to the three treatment arms at a single Russian center. Left main and chronic total occlusion were excluded, as were other scenarios for which the three procedures weren’t deemed equally feasible.

Hybrid procedures were minimally-invasive, off-pump revascularization of the left anterior descending artery with the left internal mammary artery followed by consecutive percutaneous coronary intervention (PCI) in the rest of the arteries, done in two stages within 3 days. All PCI was done with the same second-generation Xience V and Xience Prime DES.

Nearly 10% of the hybrid group (five patients) required conversion to conventional on-pump CABG with a median sternotomy for surgical technical reasons (two cases) or due to hemodynamic instability following grafting in the absence of other lesion revascularization (three cases). However, there was less with BARC 3-4 bleeding than with CABG (9.6% versus 20.0%).

The trial was sponsored by the Russian Academy of Medical Sciences.

The researchers disclosed no relevant relationships with industry.

2017-10-31T12:23:36-0400

Tagged with:

About author

Related Articles